Physician profile
Ondra Craw
NPI 1811453103
$943.52
in general payments reported to CMS, 2019-2025
11 companies · $59.69 in 2025
The $59.69 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.90 · 2022: $167 · 2023: $477 · 2024: $196 · 2025: $59.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475 · Education: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.31 |
| Education | $256.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $226.22 | 2023-2025 | Cresemba |
| Insmed, INC. | $186.27 | 2023-2024 | Arikayce |
| Tactile Systems Technology INC | $128.05 | 2022-2024 | Flexitouch Plus, Entre Plus |
| Janssen Biotech, INC. | $99.03 | 2021-2023 | Symtuza |
| Aimmune Therapeutics, INC. | $90.03 | 2024 | |
| Merck Sharp & Dohme LLC | $70.74 | 2022-2024 | Dificid, Zerbaxa, Delstrigo |
| Gilead Sciences, INC. | $39.78 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $34.61 | 2023 | Rebyota |
| Smith+Nephew, INC. | $28.89 | 2022 | |
| Abbvie INC. | $20.35 | 2021 | |
| Shionogi INC | $19.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ondra Craw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.